Top compounds associated with response to RP11-212D19.4


Feature Type Standardized
Nominal ANOVA
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.23 5e-12
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.18 1e-09
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.17 7e-09
mRNA CD-437 CTRPv2 pan-cancer AAC -0.18 5e-08
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 8e-08
mRNA barasertib CTRPv2 pan-cancer AAC -0.16 5e-07
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 8e-07
mRNA etoposide CTRPv2 pan-cancer AAC -0.15 1e-06
mRNA Topotecan CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.16 2e-06
Download CSV